ערך בספרים למניה: NewGenIvf Corp (NIVF)

NewGenIvf Group Limited maintains premium pricing in Southeast Asia due to a shortage of high-quality IVF services. The equity per share confirms this market position, where the value of 22.78 expresses the metric level. A neutral geopolitical backdrop guarantees stability, while the optimization of procurement and logistics for consumables significantly increases the operating profitability of the clinic network.

This net asset value per share reflects the residual value of NewGenIvf Group Limited assets minus liabilities, determining the intrinsic value of an investor's stake. The growth of this indicator confirms the capitalization of the ART clinic network in Southeast Asia and the effective implementation of Japanese technologies, signaling the business's long-term financial resilience to market volatility.